Adverse drug reactions associated with COVID-19 management
V Chavda, P Dodiya, V Apostolopoulos - … -Schmiedeberg's Archives of …, 2024 - Springer
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
outbreak, which causes COVID-19, had a devastating impact on both people's lives and the …
outbreak, which causes COVID-19, had a devastating impact on both people's lives and the …
Challenges in repurposing drugs in COVID-19 pandemic. Debating on potential new refinements
G Frega, A Palloni, G Di Pasquale… - Frontiers in …, 2020 - frontiersin.org
The recent worldwide spread of COVID-19 is the greatest pandemic in the last hundred
years. At the end of August, approximately 24 million cases of the SARS-CoV-2 virus have …
years. At the end of August, approximately 24 million cases of the SARS-CoV-2 virus have …
Drug Repurposing for COVID-19 Therapy
R Maldonado, F Drago - Frontiers in Pharmacology, 2021 - frontiersin.org
The rapid emergence in December 2019 of cases of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection in China rapidly expanded to multiple countries …
coronavirus 2 (SARS-CoV-2) infection in China rapidly expanded to multiple countries …
Utilizing clinical pharmacology in the drug repurposing arena: a look into COVID-19
R Ruggiero, N Balzano, R Di Napoli… - Expert Review of …, 2022 - Taylor & Francis
Introduction Drug repurposing represented an important contribution in the management of
COVID-19, becoming the first line of defense to mitigate the effects of the new coronavirus. In …
COVID-19, becoming the first line of defense to mitigate the effects of the new coronavirus. In …
Safety profile of COVID-19 drugs in a real clinical setting
MN Chiu, M Bhardwaj, SP Sah - European journal of clinical pharmacology, 2022 - Springer
Purpose The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) virus has affected millions all over the world and has …
syndrome coronavirus 2 (SARS-CoV-2) virus has affected millions all over the world and has …
DrugWAS: drug‐wide association studies for COVID‐19 drug repurposing
This study aimed to systematically investigate if any of the available drugs in the electronic
health record (EHR) can be repurposed as potential treatment for coronavirus disease 2019 …
health record (EHR) can be repurposed as potential treatment for coronavirus disease 2019 …
Drug repurposing screen for compounds inhibiting the cytopathic effect of SARS-CoV-2
CZ Chen, P Shinn, Z Itkin, RT Eastman… - Frontiers in …, 2021 - frontiersin.org
Drug repurposing is a rapid approach to identify therapeutics for the treatment of emerging
infectious diseases such as COVID-19. To address the urgent need for treatment options, we …
infectious diseases such as COVID-19. To address the urgent need for treatment options, we …
Drug repurposing for COVID-19: A review and a novel strategy to identify new targets and potential drug candidates
L Rodrigues, R Bento Cunha, T Vassilevskaia… - Molecules, 2022 - mdpi.com
In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the …
2), the causative agent of coronavirus disease 2019 (COVID-19) was first identified in the …
Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment
On 30 January 2020, the World Health Organization (WHO) declared the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic a public health emergency of …
respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic a public health emergency of …
Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies
The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
necessitates the rapid development of new therapies against coronavirus disease 2019 …
necessitates the rapid development of new therapies against coronavirus disease 2019 …